Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
On a basic level (playing devil’s advocate) why update the trial record at all? If the update is inconsequential, why update it at all? If/As P3 failed, why update it? Surely that trial is done and dusted.
If none of the above are correct, then is there not something more afoot here?
Most likely grasping at straws here, but why bother tinkering if not for a substantive purpose?
Thanks V10 - when did you receive this communication please?
Normal bid ask matching is where both sides are equal. Where one side is over loaded that is where the preference lies.
Really never seen you on this board in the last 18 months, why pop up now?!
Normal buy sell behaviour when mms want shares yes correct.
Consistently 2/3/4 v 1 on the bid this morning. I’ve not tried, but looked easy to sell this morning and mms happy to take, bearing in mind they are buying from you on the bid side. It could be because they are filling buy orders?
No way that's pi trades, surely tr1 has to come very soon
Manifesto - think you’re not quite right there. The time noted on late reported trades is that at which the trade is reported to London Stock exchange, not the time of the trade.
My understanding is that these are late reported trades from a different time, not an actual trade at 17.43. Therefore, impossible to know when the trade actually took place, hence impossible to know the buy/sell price because we don't know when the trade happened.
We can't be sure it's definitely a buy, as it's just a late reported trade, but we assume a buy due to recent historic increases by Polygon.
The most recent P2 home cohort trial last year was 100 days from LPD to results re 221 patients. Given the pressing nature of this P3 trial and the amount of company activity going on around hirings etc, I would hope that this timeline would not exceed 100 days as well.
I make the P2 home trial results being 100 days 20/1 - 30/4. Agree definitely in the results window and I don't believe that it matters about the increase in numbers from P2 to P3. They must also be increasingly aware of the commercial window of opportunity as well.
I make it that we are at 88 days since LPD rns on 11th Nov, so must be close.
Great article for SNG! When I read something like this, it makes me think that the crazy bullish sp valuations may not be too far from reality.......at some point this year.
Can't be a pi surely!?
Looking at the SNG website, this is fda crossover into the Sprinter P3, why would they bother unless it was to form the basis of the EUA in the US?
I thought the pilot was connected to Activ-2 P3 but it doesn't look like that at all.
Forgive my misunderstanding, but is this pilot anything to do with Active 2, phase 3. Because to my knowledge I don't think anyone has noticed a first patient dose confirmation or recruitment complete etc, so why do a 25 person pilot of this kind? Can't quite square the circle. Can someone educate me please?
If anyone of an age gets this, but surely the phrase, "nudge, nudge, wink, wink, say no more , say no more" was never more relevant than now!?
Historically SNG have never been one to tempt/promote like this. Constantly trying to stay positive that why would they start now if they were not confident of what they have to release in the near future
Good volume already!
Purely semantics, but if I was referring to early 2022, then I would mean by end of January. If I was meaning February, I might be inclined to refer to Q1, to allow for any slippage in timeframe.
The fact early 2022 was quoted from 11/11, says by end January to me.
Was thinking recently does each day that passes beyond 4th January mean that the likelihood of success increases. On the basis that there has now been c67 days since LPD rns, so surely they would know before now if P3 was a fail.